Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRAPPC2LP1 is a pseudogene and does not code for a functional protein. It is related by sequence to TRAPPC2L, which encodes a protein subunit of the TRAPP complex involved in vesicle tethering and protein trafficking from the endoplasmic reticulum to the Golgi apparatus. Pseudogenes generally do not have biological activity, disease relevance, or drug interactions, and are not considered therapeutic targets[7][4][5].\n\nTRAPPC2L (the functional paralog) interacts with the TRAPP complex, influencing vesicular transport and Golgi dynamics, and has been implicated in certain cellular and pathological processes[2][3][4]. TRAPPC2LP1 itself, being a pseudogene, serves no known physiological or pathological role, and should not be considered a drug target. \n\nIf your interest is in a therapeutic target relevant to vesicular trafficking, the correct entity would be *Trafficking protein particle complex subunit 2L* (abbreviated as TRAPPC2L), not TRAPPC2LP1[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex 2-like pseudogene 1 (TRAPPC2LP1).